Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis
Journal of Translational Medicine
Sayoni Das, Krystyna Taylor, James Kozubek, Jason Sardell, Steve Gardner
doi: https://doi.org/10.1186/s12967-022-03815-8
Our groundbreaking study, published in the Journal of Translational Medicine, provides the first detailed genetic insights into the pathophysiological mechanisms underpinning ME/CFS and offers new approaches for better diagnosis and treatment of patients.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease that lacks known pathogenesis, distinctive diagnostic criteria, and effective treatment options. Understanding the genetic (and other) risk factors associated with the disease would begin to help alleviate some of these issues for patients.
This is the first time that replicable genetic findings have been reported in over 30 years of study into the disease.
PrecisionLife’s ME/CFS disease architecture - SNPs are clustered by the patients in which they co-occur, with colors indicating different patient subgroups and lines showing co-association.
Sign Up